Aβ immunotherapy for Alzheimer's disease: where are we?

Neurodegener Dis Manag. 2016 Jun;6(3):179-81. doi: 10.2217/nmt-2016-0006. Epub 2016 May 27.
No abstract available

Keywords: Alzheimer's disease; amyloid-β; immunotherapy; new therapies; vaccine.

Publication types

  • Editorial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alzheimer Disease / therapy*
  • Amyloid beta-Peptides / immunology*
  • Animals
  • Clinical Trials as Topic
  • Humans
  • Immunization, Passive*
  • Immunologic Factors / therapeutic use
  • Immunotherapy, Active*

Substances

  • Amyloid beta-Peptides
  • Immunologic Factors